tm
Seeing Is Believing
tm
Seeing Is Believing
CRDF is currently covered by 4 analysts with an average price target of $5.4. This is a potential upside of $4.23 (361.54%) from yesterday's end of day stock price of $1.17.
Cardiff Oncology's activity chart (see below) currently has 37 price targets and 49 ratings on display. The stock rating distribution of CRDF is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.55% with an average time for these price targets to be met of 53.59 days.
Highest price target for CRDF is $9, Lowest price target is $2, average price target is $5.4.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 15-Sep-2026. First documented stock forecast 10-Nov-2017.
Currently out of the existing stock ratings of CRDF, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Sep-2026
$9
$7.76 (625.81%)
14 days ago
(15-Sep-2026)
0/3 (0%)
$7.66 (571.64%)
Buy Since 28-Jun-2026
$4
$2.76 (222.58%)
$4
2 months 30 days ago
(30-Jun-2026)
0/2 (0%)
$2.7 (207.69%)
Buy Since 06-Sep-2024
$2
$0.76 (61.29%)
$8
3 months 26 days ago
(03-Jun-2026)
0/2 (0%)
$0.6 (42.86%)
Buy Since 14-Apr-2025
$6
$4.76 (383.87%)
$10
7 months 4 days ago
(25-Feb-2026)
0/3 (0%)
$4.09 (214.14%)
Buy Since 22-Oct-2020
$10
$8.76 (706.45%)
$13
1 years 1 months 23 days ago
(06-Aug-2025)
0/9 (0%)
$7.56 (309.84%)
What is CRDF (Cardiff Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on CRDF (Cardiff Oncology)?
Which analyst has the most public recommendations on CRDF (Cardiff Oncology)?
Which analyst is the currently most bullish on CRDF (Cardiff Oncology)?
Which analyst is the currently most reserved on CRDF (Cardiff Oncology)?
